Edison Oncology is planning clinical trials of EO3001 targeted therapy in patients with recurrent tumors harboring a key target mutation.
More information is coming soon.
Business Development Opportunities
Please contact us if you are interested in business opportunities.
;
Careers
Join our team! Visit our website to view available opportunities and apply now.
Investors
All prospective investors, please contact us if you are interested in learning more.